Clinical trial data for GLP-1 medicines, including Ozempic, Mounjaro, Wegovy/Wegovy HD, Zepbound, and Foundayo, were reviewed to compare reported weight-loss results, FDA-approved uses, and study limitations
[4] Users should discontinue use if they experience any signs of allergic reactions, such as redness, hives, or itchiness
Some people may experience mild soreness at the injection site
Type of study: Number of citations: 2 Year: 2024 Authors: Yan Wang, Jialiang Lin, Zihao Yu, Jinbo Cheng, Jianhua Cheng, Weikang Cui Journal: Colloids and surfaces
Diabetes 2025;74 (Supplement_1):849-P
A few research studies hint that BPC-157 might also possess capabilities to encourage blood vessel formation and regulate inflammation-related activities